Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts.

Ruth RuscheweyhGregor BroessnerGudrun GoßrauKatja Heinze-KuhnTim P JürgensKatharina KaltseisKatharina KammAndreas PeikertBianca RaffaelliFlorian RimmeleStefan Evers

Published in: Cephalalgia : an international journal of headache (2020)

Under real-world conditions, individual treatment with calcitonin gene-related peptide(-receptor) antibodies was effective in 55% of our chronic cluster headache patients. This finding supports individual off-label treatment attempts with calcitonin gene-related peptide-(receptor) antibodies in chronic cluster headache patients insufficiently responding to other therapies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
copy number
prognostic factors
genome wide
gene expression
dna methylation
patient reported outcomes